Younger generations are aging faster at a biological level, a trend researchers have linked to an increased risk of developing early-onset cancer. According to a study published June 22 in Nature Medicine, individuals with a larger gap between their chronological age and their biological age face an 8% higher risk of developing solid tumors, such as those in the lungs, gastrointestinal tract, and uterus. Researchers from Washington University School of Medicine in St. Louis reached these findings by analyzing health data from over 164,000 participants in the UK Biobank and the National Institutes of Health’s All of Us Research Program.
How does biological age differ from chronological age?
Chronological age tracks the number of years a person has lived, while biological age measures the physiological state of an individual’s body. Researchers define this gap by using clinical biomarker-based tests, metabolomic age scores, and organ-specific aging metrics, according to the Nature Medicine report. This approach allows scientists to quantify how lifestyle factors, genetics, and environment influence physical health beyond the mere passage of time. The study highlights that individuals born in more recent years show a wider discrepancy between these two metrics than those in older birth cohorts.
Biological age is not fixed. Because it is influenced by metabolomic and organ-specific markers, it can theoretically be slowed or managed through targeted lifestyle interventions, though more research is required to confirm these prevention strategies.
What is the link between aging and cancer risk?
The study found that accelerated biological aging serves as a predictor for early-onset solid cancers. Data indicated that individuals with the widest age gaps faced a 15% higher risk of cancer compared to those whose biological age closely matched their chronological age. According to a June 22 news release from WashU Medicine, these findings suggest that clinical measures of accelerated aging could eventually help physicians identify high-risk patients earlier. By integrating these biomarkers into routine screenings, healthcare providers may be able to implement personalized prevention strategies before symptoms appear.
Why are younger generations showing faster biological aging?
While the study confirms that recent birth cohorts exhibit larger age gaps, it does not isolate a single cause for this acceleration. However, researchers point to the potential for “accelerated aging” to be used as a diagnostic tool. By comparing the 154,000 individuals in the UK Biobank to the 10,000 participants in the National Institutes of Health’s program, the team established a consistent pattern across different populations. This suggests that the rise in early-onset cancers may be tied to systemic factors impacting younger people, though further clinical investigation is needed to determine which specific environmental or lifestyle exposures are the primary drivers.
Frequently Asked Questions
Can I test my own biological age?
Current clinical tests for biological age, such as metabolomic age scores, are primarily used in research settings like the UK Biobank. They are not yet standard practice in routine primary care.
What is an early-onset cancer?
Early-onset cancer generally refers to cancers diagnosed in individuals younger than 50. The study specifically identified increased risks for lung, gastrointestinal, and uterine cancers.
Does a high biological age guarantee cancer?
No. The study identified an increased statistical risk, not a certainty. Researchers emphasize that these metrics are intended to help guide prevention and early detection, not to predict individual diagnoses.
Stay informed about the latest developments in oncology and preventative medicine. Subscribe to our newsletter to receive updates on how emerging biomarker research is changing patient care standards.
Have you heard of biological age testing? Share your thoughts in the comments below or explore our archives for more on the future of cancer prevention.
Related reading